Compared with sporadic MSI-H CRCs, IBD-associated colorectal cancers are characterized by some peculiarities, mainly represented by the heterogenous mismatch repair defects involving MLH1, MSH2, MSH6, or PMS2, and a low frequency of MLH1 promoter methylation [173,174]. The gene discussed is PMS2; the disease is colorectal cancer.